窥知

2008 Cervical Cancer guideline Chinese edition.pdf Copyright © National Comprehensive Cancer Network 2008. All rights reserved. “NCCN”, the NCCN logo, and “National Comprehensive Cancer Network” are registered trademarks of the National Comprehensive Cancer Network. The Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Cervical Cancer Guideline 2008 is the Chinese adapted version of NCCN Clinical Practice Guidelines in Oncology-Cervical Cancer Guideline, V.1.2008 as permitted and endorsed by NCCN. It is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. The original guideline and Chinese edition are both available at: http://www.nccn.org. To view the most recent and complete version of the guideline, go online to www.nccn.org. These Guidelines and illustrations herein may not be reproduced in any form for any purpose without the express written permission of the NCCN. These Guidelines are a work in progress that will be refined as often as new significant data becomes available. The NCCN Guidelines are a statement of consensus of its authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult any NCCN guideline is expected to use independent medical judgment in the context of individual clinical circumstance to determine any patient's care or treatment. The National Comprehensive Cancer Network makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. This publication should not be used for commercial purpose. It is provided for free to Chinese medical professions with the support of the unrestrictive educational grant of GlaxoSmithKline (China) Investment Co. Ltd. which exerts no influence to the formation of the Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Cervical Cancer Guideline 2008. NCCN ® 肿瘤学临床实践指南(中国版)2008年 第一版 © National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. The Chinese edition 2008 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org. 宫颈癌 NCCN宫颈癌专家组成员 * Benjamin E.Greer, MD/Co-Chair Ω Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance * Wui-Jin Koh, MD/Co-Chair § Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance Nadeem R. Abu-Rustum, MD Ω Memorial Sloan-Kettering Cancer Center Michael A. Bookman, MD † Fox Chase Cancer Center Robert E. Bristow, MD Ω The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Susana Campos, MD † Dana-Farber / Brigham and Women′s Cancer Center | Massachusetts General Hospital Cancer Center Kathleen R. Cho, MD ≠ University of Michigan Comprehensive Cancer Center Larry Copeland, MD Ω Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University Patricia Eifel, MD § The University of Texas M. D. Anderson Cancer Center Warner K. Huh, MD Ω University of Alabama at Birmingham Comprehensive Cancer Center Wainwright Jaggernauth, MD § Roswell Park Cancer Institute Daniel S. Kapp, MD, PhD § Stanford Comprehensive Cancer Center John Kavanagh, MD † The University of Texas M. D. Anderson Cancer Center Gary H. Lipscomb, MD Ω St. Jude Children′s Research Hospital/University of Tennessee JohnR. Lurain, III, MD Ω Robert H. Lurie Comprehensive Cancer Center of Northwestern University Mark A. Morgan, MD Ω Fox Chase Cancer Center Robert J. Morgan, Jr., MD † ‡ City of Hope C. Bethan Powell, MD Ω UCSF Comprehensive Cancer Center Steven W. Remmenga, MD Ω UNMC Eppley Cancer Center at The Nebraska Medical Center R. Kevin Reynolds, MD Ω University of Michigan Comprehensive Cancer Center Angeles Alvarez Secord, MD Ω Duke Comprehensive Cancer Center * William Small, Jr., MD § Robert H. Lurie Comprehensive Cancer Center of Northwestern University Nelson Teng, MD, PhD Ω Stanford Comprehensive Cancer Center 妇科肿瘤 肿瘤内科 血液科 放疗科/放射肿瘤科 病理科 编委会成员 Ω † ‡ § ≠ * NCCN ®宫颈癌 肿瘤学临床实践指南(中国版)2008年 第一版 © National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. The Chinese edition 2008 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org. NCCN特别鸣谢 NCCN指南中国版专家组 召集人： 孙 燕 中国医学科学院协和医科大学 肿瘤医院 NCCN代表： Benjamin E. Greer, MD Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance NCCN宫颈癌临床实践指南（中国版）专家组 组 长： 郎景和 北京协和医院 成 员（按拼音排序）： 崔 恒 北京大学人民医院 狄 文 上海交通大学医学院附属仁济医院 丰有吉 复旦大学附属妇产科医院 高雨农 北京大学临床肿瘤学院、北京肿瘤医院 郭丽娜 北京协和医院 郝 权 天津市肿瘤医院、天津医科大学附属肿瘤医院 孔北华 山东大学齐鲁医院 李 力 广西医科大学附属肿瘤医院 李子庭 复旦大学附属肿瘤医院 刘继红 中山大学附属肿瘤医院 执笔人： 吴小华 复旦大学附属肿瘤医院 刘丽影 中国医学科学院协和医科大学肿瘤医院 马 丁 华中科技大学同济医学院附属同济医院 沈 铿 北京协和医院 宋 磊 中国人民解放军总医院(三○一医院) 魏丽惠 北京大学人民医院 吴 鸣 北京协和医院 吴令英 中国医学科学院协和医科大学肿瘤医院 向 阳 北京协和医院 谢 幸 浙江大学医学院附属妇产科医院 张福泉 北京协和医院 NCCN ® 肿瘤学临床实践指南(中国版)2008年 第一版 © National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. The Chinese edition 2008 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org. 宫颈癌 目录 NCCN宫颈癌专家组成员 NCCN特别鸣谢 临床分期（CERV-1） IA1期（CERV-2） IA2、IB1期和IIA期（≤4 cm）（CERV-2） IB2和IIA期（＞4 cm）（CERV-2） 部分巨块型IB2期、IIA期和IIB、IIIA、IIIB、IVA期（CERV-4） 单纯子宫切除时意外发现的宫颈浸润癌（CERV-7） 监测（CERV-8） 盆腔复发（CERV-9） 盆腔外和腹主动脉旁淋巴结复发（CERV-10） 宫颈癌的化疗方案（CERV-A） 分期 文稿 参考文献 临床试验：NCCN认为任何肿瘤患者都可以在临床试验中得到最 佳处理，因此特别鼓励肿瘤患者参加临床试验研究。 NCCN对证据和共识的分类： 除非特别指出，NCCN对所有建议均达成2A类共识。 见NCCN对证据和共识的分类 作为共识，NCCN肿瘤学临床实践指南反映了作者们对目前认可的治疗方法的观点，欲参考或应用这些指南的临床医师应根据个人具体的临床情况做出独立的医疗判断，以决定患者所需的护理和治 疗。任何寻求使用这些指南的病人或非医生人员应咨询医生关于它们的合理应用。 NCCN肿瘤学临床实践指南编译力求精确表达反映原版英文指南。NCCN不保证指南编译的有效性，也不承认任何无限制性的担保、表达及暗示。NCCN不担保指南编译或指南本身的精确性和完整 性。NCCN不保证或担保或陈述指南的应用及应用结果。NCCN及其成员不对涉及指南无限制性应用的任何偶然的、间接的、特殊的、惩罚性或作为结果的补偿费承担任何责任。 声明： 本指南中标注“※”处为中国专家根据国内实际情况进行明显 改动或补充之处，内容有别于英文版，参考时请注意。 ...